Detalles de la búsqueda
1.
Mimics and artefacts of measurable residual disease in a highly sensitive multicolour flow cytometry assay for B-lymphoblastic leukaemia/lymphoma: critical consideration for analysis of measurable residual disease.
Br J Haematol
; 196(2): 374-379, 2022 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34476808
2.
Comprehensive immune cell profiling depicts an early immune response associated with severe coronavirus disease 2019 in cancer patients.
Immunol Cell Biol
; 100(1): 61-73, 2022 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34582592
3.
Decreased expression of cell adhesion genes in cancer stem-like cells isolated from primary oral squamous cell carcinomas.
Tumour Biol
; 40(5): 1010428318780859, 2018 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-29888653
4.
Circulating tumor plasma cells and peripheral blood measurable residual disease assessment in multiple myeloma patients not planned for upfront transplant.
Hemasphere
; 8(4): e63, 2024 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-38566804
5.
Detecting hypodiploidy with endoreduplication and masked hypodiploidy in B-cell acute lymphoblastic leukemia using multicolor flow cytometry.
Cytometry B Clin Cytom
; 102(3): 199-208, 2022 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-35212133
6.
Expression levels and patterns of B-cell maturation antigen in newly diagnosed and relapsed multiple myeloma patients from Indian subcontinent.
Cytometry B Clin Cytom
; 102(6): 462-470, 2022 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-36346307
7.
Improved protocol for plasma microRNA extraction and comparison of commercial kits.
Biochem Med (Zagreb)
; 31(3): 030705, 2021 Oct 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-34658646
8.
Immunophenotypic shift in the B-cell precursors from regenerating bone marrow samples: A critical consideration for measurable residual disease assessment in B-lymphoblastic leukemia.
Cytometry B Clin Cytom
; 100(4): 434-445, 2021 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-32896101
9.
Eleven-marker 10-color flow cytometric assessment of measurable residual disease for T-cell acute lymphoblastic leukemia using an approach of exclusion.
Cytometry B Clin Cytom
; 100(4): 421-433, 2021 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-32812702
10.
Flow cytometric evaluation of CD38 expression levels in the newly diagnosed T-cell acute lymphoblastic leukemia and the effect of chemotherapy on its expression in measurable residual disease, refractory disease and relapsed disease: an implication for anti-CD38 immunotherapy.
J Immunother Cancer
; 8(1)2020 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-32439800
11.
Potential role of cancer stem cells as biomarkers and therapeutic targets in cervical cancer.
Cancer Rep (Hoboken)
; 2(2): e1144, 2019 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-32721115
Resultados
1 -
11
de 11
1
Próxima >
>>